Drug companies criticised for exaggerationBMJ 1999; 318 doi: https://doi.org/10.1136/bmj.318.7189.962 (Published 10 April 1999) Cite this as: BMJ 1999;318:962
- Annabel Ferriman
Complaints against pharmaceutical companies for breaching the industry's voluntary advertising code of practice remained at high levels in 1998, according to a report from the Prescription Medicines Code of Practice Authority.
The authority received 144 complaints, only one less than the record set in 1994 and reached again in 1997. The authority was set up in 1993 by the Association of the British Pharmaceutical Industry (ABPI) to police the code; since then it has dealt with over 640 complaints.
Its latest quarterly report reveals that 36 complaints were dealt with in the last quarter of 1998, 27 of which were upheld. The companies receiving the most were Astra (5); Glaxo …